Advocacy groups play a crucial role in both driving access to innovative treatment and services and educating patients and caregivers on novel breakthroughs.
KOL identification and KOL mapping are often spoken about together, often treated as the same entity would simply a difference in terminology. They are however very different, yet synergistic.